Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Phase 2 Completed
24 enrolled 14 charts
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
240 enrolled 14 charts
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
42 enrolled
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
Phase 1/2 Completed
111 enrolled 22 charts
Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Phase 3 Completed
572 enrolled
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Phase 2 Completed
136 enrolled 13 charts
ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Phase 3 Completed
1,010 enrolled 22 charts
Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
Phase 2 Completed
36 enrolled 8 charts
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer
Phase 2 Completed
169 enrolled
Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery
Phase 3 Completed
2,559 enrolled
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Phase 3 Completed
3,397 enrolled 24 charts
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
2,334 enrolled 9 charts
AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
Phase 1 Completed
10 enrolled
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
37 enrolled
BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer
Phase 2 Completed
51 enrolled 11 charts
A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)
Phase 1 Completed
20 enrolled
Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response
Phase 2 Completed
28 enrolled
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 2 Completed
73 enrolled
Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
Phase 2 Completed
35 enrolled 7 charts
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
Phase 1 Completed
43 enrolled
Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer
Phase 2 Completed
66 enrolled 7 charts
Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
Phase 2 Completed
70 enrolled
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
Phase 1/2 Completed
17 enrolled 7 charts
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer
Phase 1/2 Completed
66 enrolled
Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors
Phase 1 Completed
33 enrolled
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 1 Completed
48 enrolled
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
Phase 2/3 Completed
3,240 enrolled
Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer
Phase 2 Completed
110 enrolled
Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
17 enrolled 15 charts
ERBIFORT
Phase 2 Completed
24 enrolled
Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
74 enrolled
Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery
Phase 2 Completed
45 enrolled
Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Completed
80 enrolled
Cetuximab in Treating Patients With Stage IV Colorectal Cancer
Phase 2 Completed